538 related articles for article (PubMed ID: 20221459)
21. Phototoxicity of a core-modified porphyrin and induction of apoptosis.
You Y; Gibson SL; Detty MR
J Photochem Photobiol B; 2006 Dec; 85(3):155-62. PubMed ID: 16905327
[TBL] [Abstract][Full Text] [Related]
22. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
Wong Kee Song LM; Wang KK; Zinsmeister AR
Cancer; 1998 Jan; 82(2):421-7. PubMed ID: 9445202
[TBL] [Abstract][Full Text] [Related]
23. 31P magnetic resonance spectroscopy as a predictor of efficacy in photodynamic therapy using differently charged zinc phthalocyanines.
Bremner JC; Wood SR; Bradley JK; Griffiths J; Adams GE; Brown SB
Br J Cancer; 1999 Oct; 81(4):616-21. PubMed ID: 10574246
[TBL] [Abstract][Full Text] [Related]
24. Conjugation of chlorin p(6) to histamine enhances its cellular uptake and phototoxicity in oral cancer cells.
Parihar A; Dube A; Gupta PK
Cancer Chemother Pharmacol; 2011 Aug; 68(2):359-69. PubMed ID: 20978762
[TBL] [Abstract][Full Text] [Related]
25. Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes.
Maugain E; Sasnouski S; Zorin V; Merlin JL; Guillemin F; Bezdetnaya L
Oncol Rep; 2004 Sep; 12(3):639-45. PubMed ID: 15289849
[TBL] [Abstract][Full Text] [Related]
26. Tissue uptake study and photodynamic therapy of melanoma-bearing mice with a nontoxic, effective chlorin.
Dąbrowski JM; Krzykawska M; Arnaut LG; Pereira MM; Monteiro CJ; Simões S; Urbańska K; Stochel G
ChemMedChem; 2011 Sep; 6(9):1715-26. PubMed ID: 21732537
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse.
Kobayashi W; Liu Q; Nakagawa H; Sakaki H; Teh B; Matsumiya T; Yoshida H; Imaizumi T; Satoh K; Kimura H
Oral Oncol; 2006 Jan; 42(1):46-50. PubMed ID: 16266818
[TBL] [Abstract][Full Text] [Related]
28. Tissue distribution and in vivo photosensitizing activity of 13,15-[N-(3-hydroxypropyl)]cycloimide chlorin p6 and 13,15-(N-methoxy)cycloimide chlorin p6 methyl ester.
Karmakova T; Feofanov A; Pankratov A; Kazachkina N; Nazarova A; Yakubovskaya R; Lebedeva V; Ruziyev R; Mironov A; Maurizot JC; Vigny P
J Photochem Photobiol B; 2006 Jan; 82(1):28-36. PubMed ID: 16236520
[TBL] [Abstract][Full Text] [Related]
29. Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma.
Peng Q; Moan J; Ma LW; Nesland JM
Cancer Res; 1995 Jun; 55(12):2620-6. PubMed ID: 7780978
[TBL] [Abstract][Full Text] [Related]
30. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
31. Parabolic quantitative structure-activity relationships and photodynamic therapy: application of a three-compartment model with clearance to the in vivo quantitative structure-activity relationships of a congeneric series of pyropheophorbide derivatives used as photosensitizers for photodynamic therapy.
Potter WR; Henderson BW; Bellnier DA; Pandey RK; Vaughan LA; Weishaupt KR; Dougherty TJ
Photochem Photobiol; 1999 Nov; 70(5):781-8. PubMed ID: 10568170
[TBL] [Abstract][Full Text] [Related]
32. Developing a structure-function relationship for anionic porphyrazines exhibiting selective anti-tumor activity.
Vesper BJ; Lee S; Hammer ND; Elseth KM; Barrett AG; Hoffman BM; Radosevich JA
J Photochem Photobiol B; 2006 Mar; 82(3):180-6. PubMed ID: 16388964
[TBL] [Abstract][Full Text] [Related]
33. Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer.
Takeuchi Y; Kurohane K; Ichikawa K; Yonezawa S; Nango M; Oku N
Cancer; 2003 Apr; 97(8):2027-34. PubMed ID: 12673734
[TBL] [Abstract][Full Text] [Related]
34. Light-harvesting ionic dendrimer porphyrins as new photosensitizers for photodynamic therapy.
Nishiyama N; Stapert HR; Zhang GD; Takasu D; Jiang DL; Nagano T; Aida T; Kataoka K
Bioconjug Chem; 2003; 14(1):58-66. PubMed ID: 12526693
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic, toxicological and phototherapeutic studies of phthalocyanine ZnPcCF3.
Milla LN; Yslas EI; Cabral A; Durantini EN; Romanini S; Rivarola V; Bertuzzi M
Biomed Pharmacother; 2009 Mar; 63(3):209-15. PubMed ID: 18599256
[TBL] [Abstract][Full Text] [Related]
36. Monitoring of singlet oxygen is useful for predicting the photodynamic effects in the treatment for experimental glioma.
Yamamoto J; Yamamoto S; Hirano T; Li S; Koide M; Kohno E; Okada M; Inenaga C; Tokuyama T; Yokota N; Terakawa S; Namba H
Clin Cancer Res; 2006 Dec; 12(23):7132-9. PubMed ID: 17145838
[TBL] [Abstract][Full Text] [Related]
37. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model.
Gomer CJ; Ferrario A
Cancer Res; 1990 Jul; 50(13):3985-90. PubMed ID: 2354446
[TBL] [Abstract][Full Text] [Related]
38. Effect of zinc insertion and hydrophobicity on the membrane interactions and PDT activity of porphyrin photosensitizers.
Pavani C; Uchoa AF; Oliveira CS; Iamamoto Y; Baptista MS
Photochem Photobiol Sci; 2009 Feb; 8(2):233-40. PubMed ID: 19247516
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
Chan AL; Juarez M; Allen R; Volz W; Albertson T
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):72-8. PubMed ID: 15752124
[TBL] [Abstract][Full Text] [Related]
40. Hexadecafluorinated zinc phthalocyanine: photodynamic properties against the EMT-6 tumour in mice and pharmacokinetics using 65Zn as a radiotracer.
Boyle RW; Rousseau J; Kudrevich SV; Obochi M; van Lier JE
Br J Cancer; 1996 Jan; 73(1):49-53. PubMed ID: 8554982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
